• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Schizophrenia Therapeutic Market How The Market Will Witness Substantial Growth in the Upcoming years | AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company

January 17th, 2022 Coherent Market Insights Releases

Schizophrenia is a mental disorder in which the patient suffers from strange speech, abnormal behavior, loss of ability to think, and inability to understand reality. Moreover, the patient suffers from less social engagement, depression, anxiety, or less emotional expression. Schizophrenia typically occurs between the ages of 16-30, according to the Brain and Behavior Research Foundation. However, the underlying cause of schizophrenia is unknown, the possible causes are genetic, environmental factors or poor nutrition during pregnancy.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2468

Treatments for schizophrenia count antipsychotic medications, behavioural therapy, and psychotherapy. Electroconvulsive therapies also help treat schizophrenia. In serious cases, short-term hospitalization is required.

Global Schizophrenia Therapeutic Market- Drivers

Due to the increasing prevalence of schizophrenia, the global schizophrenia therapeutic market is expected to grow in size. The World Health Organization (WHO) reported that more than 23 million patients worldwide are affected by schizophrenia in 2018. Moreover, increasing approval of treatments with second-generation antipsychotic drugs like, lurasidone, olanzapine, paliperidone, and risperidone, which have fewer side effects, is expected to increase revenue in the global schizophrenia treatment market. For example, the U.S. Food and Drug Administration (FDA) approved Vraylar (Cariprazine) in 2015, which was tested on 1,750 patients. The drug effectively reduced the symptoms of schizophrenia in a short time.

Global Schizophrenia Therapeutic- Restraints

General carelessness and stigma about schizophrenia is a major deterrent to the growth of the global schizophrenia therapeutic market. For example, in 2018, the Schizophrenia and Related Disorders Alliance of America (SARDAA) reported that due to neglect of mental health, about 50% of people diagnosed with schizophrenia do not receive treatment.

Furthermore, side effects caused by antipsychotics like constipation, epilepsy, low blood pressure, blurred vision, nausea, malaise, dizziness, and weight gain, may also be a rendering factor of negative growth for global schizophrenia therapeutic market earnings. For example, according to the findings of the National Center for Biotechnology Information (NCBI) 2017, obesity affects 15% -72% of patients, 12% of patients with diabetes and 39% of constipation in schizophrenic patients. The use of antipsychotics can lead to sudden cardiac death and even ventricular arrhythmia.

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2468

Global Schizophrenia Therapeutic Market- Regional Analysis

Due to the increasing incidence of schizophrenia and large investments in schizophrenia therapy in the region, North America has a strong position in the schizophrenia therapeutic market. According to SARDAA, approximately 3.2 to 3.5 million people in the U.S. suffered from schizophrenia in 2013. According to the same source, approximately US $ 32 to US $ 65 billion is spent annually on treatment of schizophrenia and other financial costs in the US.

Asia Pacific is the fastest growing region in the global schizophrenia therapeutic market due to the high prevalence of schizophrenia in economies like China and India. According to NCBI 2014 data, the prevalence rate of schizophrenia in China was 4.62 per 1000 people. The launch of new drugs in China is expected to increase the size of the global schizophrenia therapeutic market. For example, in 2018, Johnson & Johnson’s Janssen Pharmaceutical companies launched INVEGA TRINZA for the treatment of schizophrenia in China. INVEGA TRINZA is a three-month long-acting atypical antipsychotic drug for insomnia.

Global Schizophrenia Therapeutic Market- Segmentation

On the basis of Drug Type, the Global Schizophrenia Therapeutic Market is segmented into:

  • First Generation Antipsychotic Drugs
  • Second Generation Antipsychotic Drugs

On the basis of Distribution Channel, the Global Schizophrenia Therapeutic Market is segmented into:

  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy

On the basis of Region, the Global Schizophrenia Therapeutic Market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Global Schizophrenia Therapeutic Market- Competitive Landscape

Key players performing in the global schizophrenia therapeutic market are Sumitomo Dainippon Pharma, Allergan (Forest Labs), Alkermes, Otsuka Pharmaceuticals, Novartis AG, Intas Pharmaceuticals, Sandoz Canada Inc., Pfizer, Johnson & Johnson, Eli Lilly and Company, Bristol-Myers Squibb, and AstraZeneca.

Buy This Complete Business Report With Flat USD 2000 Off@ https://www.coherentmarketinsights.com/promo/buynow/2468

Reasons to Purchase This Report

• Current and future of Schizophrenia Therapeutic Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Schizophrenia Therapeutic Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Schizophrenia Therapeutic Industry Impact

Chapter 2 Global Schizophrenia Therapeutic Competition by Types, Applications, and Top Regions and Countries
2.1 Global Schizophrenia Therapeutic (Volume and Value) by Type
2.3 Global Schizophrenia Therapeutic (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Schizophrenia Therapeutic Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Schizophrenia Therapeutic Market Analysis
Chapter 6 East Asia Schizophrenia Therapeutic Market Analysis
Chapter 7 Europe Schizophrenia Therapeutic Market Analysis
Chapter 8 South Asia Schizophrenia Therapeutic Market Analysis
Chapter 9 Southeast Asia Schizophrenia Therapeutic Market Analysis
Chapter 10 Middle East Schizophrenia Therapeutic Market Analysis
Chapter 11 Africa Schizophrenia Therapeutic Market Analysis
Chapter 12 Oceania Schizophrenia Therapeutic Market Analysis
Chapter 13 South America Schizophrenia Therapeutic Market Analysis
Chapter 14 Company Profiles and Key Figures in Schizophrenia Therapeutic Business
Chapter 15 Global Schizophrenia Therapeutic Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/2468

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email